Kenyon Farrow
Senior EditorKenyon is the senior editor of TheBody/TheBodyPro. He has a distinguished track record working in communities impacted by HIV as an activist, writer, and strategist, stretching back long before he joined our team in late 2017. Kenyon's work has been recognized by many institutions, including Out Magazine's "Out 100" and The Advocate's "40 Under 40." He was also named a "Modern Black History Hero" by Black Entertainment Television.
Latest by Kenyon Farrow
Racism and Homophobia in Health Care Settings May Reduce PrEP Uptake for Young Black Gay and Bisexual Men, Study Finds
Racial segregation and medical mistrust in Milwaukee may keep pre-exposure prophylaxis out of their hands.
After Pilot, Whitman-Walker Health Establishes Same-Day HIV Treatment Start Program
"We're very much putting the patient in the driver's seat," said Heather Alt, deputy director of nursing with Whitman-Walker. "If folks didn't feel ready, we would not push them to start."
Study Finds Long-Acting HIV Meds Are Acceptable to Many People, but Differences Exist Among Groups
People with college education, gay and bisexual men, and people who struggle to make clinic visits were more likely to prefer the long-acting option.
Researchers Discuss Ethics and Privacy Concerns About the Growing Field of HIV Adherence Monitoring
"A lot of patients want to know, 'Who else is going to see this data?'" said Peter Chai of Fenway Health in Boston.
Government Panel Finds PrEP Is Effective, Must Be Available Free of Cost to Patients
The US Preventive Services Task Force released its final ruling in *JAMA*.
New Campaign, Toolkit Gets Providers PrEP'd for Women
New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.
Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare
Providers, payers, and health systems need to catch up, said Melanie Thompson, M.D., at the ACTHIV conference.
Drug Use May Be Increasing Syphilis Rates Among HIV-Positive Cisgender Women, Studies Show
The global increase in sexually transmitted infections was a major focus of the CROI 2019 meeting in Seattle, Washington.
What You Need to Know About the Second Person Likely Cured of HIV
Richard Jefferys, an expert in HIV cure research, spoke to TheBodyPro about this new case of HIV remission -- and the danger in rushing to publish these stories, especially for people who live with stigma.
Pharma Payments to Doctors Associated With Spike in Opioid Deaths, New Study Reveals
After years of anecdotes and speculation, harm reduction and pharma watchdog advocates have data to back claims that the spike in opioid deaths in the U.S. can be tied to pharmaceutical companies marketing highly addictive opioids to doctors.